IGC Pharma, Inc. (IGC): Total Liabilities

Annual figures by period end, from SEC filings.

Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$2.42M
As of 2025-03-31
-6.3%
3-year compound annual growth
-0.2%
5-year compound annual growth
-8.0%
10-year compound annual growth
$9.44M2011-03-31: $7.79M2012-03-31: $9.44M2013-03-31: $4.28M2014-03-31: $3.59M2015-03-31: $5.58M2016-03-31: $4.91M2017-03-31: $3.93M2018-03-31: $2.79M2019-03-31: $893.0K2020-03-31: $2.45M2021-03-31: $3.06M2022-03-31: $2.94M2023-03-31: $2.27M2024-03-31: $2.58M2025-03-31: $2.42M$2.42M
2011-03-31 Total Liabilities (USD) 2025-03-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-03-31$2.42M-6.4%2025-06-27, Balance as of period end
2024-03-31$2.58M+13.9%2025-06-27, Balance as of period end
2023-03-31$2.27M-22.9%2024-06-24, Balance as of period end
2022-03-31$2.94M-4.0%2023-07-07, Balance as of period end
2021-03-31$3.06M+25.2%2022-06-23, Balance as of period end
2020-03-31$2.45M+174.0%2021-06-14, Balance as of period end
2019-03-31$893.0K-68.0%2020-07-13, Balance as of period end
2018-03-31$2.79M-29.1%2019-06-14, Balance as of period end
2017-03-31$3.93M-19.9%2018-06-21, Balance as of period end
2016-03-31$4.91M-12.0%2017-07-14, Balance as of period end
2015-03-31$5.58M+55.5%2016-07-14, Balance as of period end
2014-03-31$3.59M-16.1%2015-07-14, Balance as of period end
2013-03-31$4.28M-54.7%2014-07-15, Balance as of period end
2012-03-31$9.44M+21.3%2014-07-15, Balance as of period end
2011-03-31$7.79Mn/a2012-07-16, Balance as of period end